Fingerprint Dive into the research topics where IM-Hem Onc BMT is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

  • Network Recent external collaboration on country level. Dive into details by clicking on the dots.


    Research Output

    Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib

    Awan, F. T., Schuh, A., Brown, J. R., Furman, R. R., Pagel, J. M., Hillmen, P., Stephens, D. M., Woyach, J., Bibikova, E., Charuworn, P., Frigault, M. M., Hamdy, A., Izumi, R., Linghu, B., Patel, P., Wang, M. H. & Byrd, J. C., Jan 1 2019, In : Blood Advances. 3, 9, p. 1553-1562 10 p.

    Research output: Contribution to journalArticle

  • 12 Scopus citations

    Banking on a cooperative effort

    Chung, S. S., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

    Research output: Contribution to journalComment/debate

    Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma

    Bond, D. A., Dotson, E., Awan, F. T., Baiocchi, R. A., Blum, K. A. & Maddocks, K., Mar 2019, In : Clinical Lymphoma, Myeloma and Leukemia. 19, 3, p. e123-e128

    Research output: Contribution to journalArticle